Exercise News and Research

Latest Exercise News and Research

CPEX Pharmaceuticals' Phase 2a Nasulin trial fails, Arcadia Capital Advisors issues statement

Richard S. Rofe, who serves as Managing Director for Arcadia Capital Advisors, LLC, and is part of a shareholder group that includes Arcadia with a 9.97 percent ownership interest in CPEX Pharmaceuticals, Inc.,, commented on CPEX's recent announcement of failed Phase 2a Nasulin study results.

19 Mar 2010

Community-driven approaches needed for reducing cancer-death disparities

Cancer death rates for African-Americans far exceed non-Hispanic Caucasians in the United States, and only community-driven approaches to reducing health disparities will lessen the gap, says Edward Partridge, M.D., president-elect of the American Cancer Society (ACS) National Board of Directors and director of the University of Alabama at Birmingham (UAB) Comprehensive Cancer Center.

19 Mar 2010

Lifestyle improvements and new treatments for diabetes and cardiovascular disease needed

Treatment with the anti-hypertensive drug valsartan (Diovan) led to a modest reduction in the development of type 2 diabetes but did not significantly reduce cardiovascular events in patients with impaired glucose tolerance, according to researchers at Duke University Medical Center and the University of Oxford. They jointly reported results at the American College of Cardiology meeting today from the world's first study designed to find ways to control the progression to diabetes and cardiovascular disease in people at risk.

19 Mar 2010

Role of structured physical activity in preventing or delaying mobility disabilities in older adults

Wake Forest University Baptist Medical Center, together with Wake Forest University, will play a key role in a new study that seeks to determine whether a program of structured physical activity can prevent or delay major mobility disabilities in older adults.

19 Mar 2010

Physician scientists present new findings on aspirin therapy, atrial fibrillation drug therapy and LVAD

Physician scientists from the Cedars-Sinai Heart Institute presented new findings on the effectiveness of routine aspirin therapy for preventing heart disease, a drug therapy for atrial fibrillation and the role left ventricular assist devices may play in weight reduction for obese patients with chronic end-stage heart failure who are considered for heart transplantation.

19 Mar 2010

Diabetes patients who have lower tendency to reach out to others have higher mortality rate: Study

Mistrust can exact a high toll. Being overly cautious or dismissive in relating to people, researchers are learning, may shorten the lives of people with diabetes.

19 Mar 2010

Coercing Congress members to vote for healthcare plan: Physicians' file lawsuit

On Thursday, March 18, lawyers from the U.S. Department of Justice will appear in Federal District Court for oral argument in opposition to a request by physicians opposed to President Barack Obama's healthcare bill for an injunction barring his Administration "from undertaking in the future to intimidate or coerce any member of Congress" to vote for the plan.

19 Mar 2010

Mrs. Obama on childhood obesity

Last month First Lady Michelle Obama launched a programme called “Let’s Move” aiming at reducing and eradicating the childhood obesity epidemic in the existing generation so that the nation as a whole attains a healthy adulthood in the coming decades.

18 Mar 2010

Popular home video game system modified to help teenagers with cerebral palsy improve hand functions

Tips to avoid exercise-related injuries in baby boomers

The March issue of Mayo Clinic Women's HealthSource covers what's behind boomeritis. Baby boomers, now in their 50s and 60s, are fitter and more athletic longer into their lives, compared with their parents' generation.

18 Mar 2010

Studies link atmospheric CO pollution to adverse cardiovascular outcomes, cardiac mortality

In the healthy rat, prolonged exposure to carbon monoxide (CO) under conditions that mimic urban pollution leads to changes to cardiac morphology and function. Compensatory mechanisms develop in these animals to sustain normal cardiac activity, but they become more vulnerable to heart disease.

18 Mar 2010

Health overhaul supporters, critics duel on airwaves

McClatchy/Miami Herald: "As a historic vote on sweeping healthcare legislation nears, Democratic moderates in the House of Representatives face relentless pressure as they juggle personal pleas from President Barack Obama, a multimillion-dollar ad barrage and constituents who are fed up with the convoluted congressional process.

18 Mar 2010

Nabi Biopharmaceuticals commences second Phase III study of NicVAX for treating nicotine addiction

Nabi Biopharmaceuticals announced that it has initiated the second of two pivotal Phase III clinical trials for NicVAX® (Nicotine Conjugate Vaccine), the company's innovative and proprietary vaccine to treat nicotine addiction and prevent smoking relapse. The FDA has agreed with Nabi on the study design, protocol and end points through a Special Protocol Assessment (SPA). The SPA forms a basic foundation to support approval of a New Drug Application. The Company also received scientific advice from the European Medicines Agency (EMEA) that confirms and supports the trial protocol.

17 Mar 2010

ONGLYZA-metformin combination: FDA accepts NDA for review

Bristol-Myers Squibb Company and AstraZeneca today announced that the U.S. Food and Drug Administration (FDA) has accepted for review a New Drug Application (NDA) for an investigational fixed dose combination of ONGLYZA™ (saxagliptin), a dipeptidyl peptidase-4 (DPP4) inhibitor, and metformin HCl extended-release tablets as a once-daily treatment for type 2 diabetes mellitus in adults.

17 Mar 2010

FDA approves Medtronic's MiniMed Paradigm integrated diabetes management system

Medtronic, Inc. today announced it has received U.S. Food and Drug Administration (FDA) approval for the MiniMed Paradigm® REAL-Time Revel™ System, the next generation of the industry’s only integrated diabetes management system (insulin pump therapy, continuous glucose monitoring (CGM) and diabetes therapy management software).

17 Mar 2010

Meridian Bioscience revises fiscal 2010 guidance, expects net sales between $145M and $153M

Meridian Bioscience, Inc., Cincinnati, Ohio today announced that it is revising downward its previous sales and earnings guidance for the fiscal year ending September 30, 2010. This action is being taken as a result of weaker than expected operating results for the second quarter ending March 31, 2010, based on preliminary results to date. Separately, Meridian announced that it will file a 510(k) for FDA marketing clearance next week in connection with its illumigene™ C. difficile product.

17 Mar 2010

Low-impact, weight-bearing exercise does not affect bone density during weight loss

While there are many benefits of losing weight, weight reduction also might negatively affect bones in the body. During weight loss, bones are being remodeled - breaking down old bone and forming new bone - at an accelerated rate.

17 Mar 2010

Study analyzes mortality rates of patients after coronary angioplasty

A team of Mayo Clinic researchers have found that cardiac rehabilitation is associated with significantly reduced mortality rates for patients who have had stents placed to treat blockages in their coronary arteries.

17 Mar 2010

Obese patients face lower risk of sudden cardiac death compared to non-obese patients

Obesity has long been identified as a risk factor for cardiovascular disease and heart failure. But, a new study conducted by researchers at the University of Rochester Medical Center found that being skinny confers no advantage when it comes to the risk of dying suddenly from cardiac causes.

17 Mar 2010

Blocking RhoA enzyme increases survival in SMA mouse model

Scientists from the Ottawa Hospital Research Institute (OHRI) and the University of Ottawa have identified a promising new approach for developing drugs to treat Spinal muscular atrophy (SMA), the leading inherited cause of death in infants and toddlers. Dr. Rashmi Kothary and his doctoral student Melissa Bowerman have found that an enzyme called RhoA is overly active in a mouse model of the disease and blocking this enzyme can greatly increase survival. The study is published in Human Molecular Genetics.

16 Mar 2010

Exercise News and Research

Latest Exercise News and Research

CPEX Pharmaceuticals' Phase 2a Nasulin trial fails, Arcadia Capital Advisors issues statement

Community-driven approaches needed for reducing cancer-death disparities

Lifestyle improvements and new treatments for diabetes and cardiovascular disease needed

Role of structured physical activity in preventing or delaying mobility disabilities in older adults

Physician scientists present new findings on aspirin therapy, atrial fibrillation drug therapy and LVAD

Diabetes patients who have lower tendency to reach out to others have higher mortality rate: Study

Coercing Congress members to vote for healthcare plan: Physicians' file lawsuit

Mrs. Obama on childhood obesity

Popular home video game system modified to help teenagers with cerebral palsy improve hand functions

Tips to avoid exercise-related injuries in baby boomers

Studies link atmospheric CO pollution to adverse cardiovascular outcomes, cardiac mortality

Health overhaul supporters, critics duel on airwaves

Nabi Biopharmaceuticals commences second Phase III study of NicVAX for treating nicotine addiction

ONGLYZA-metformin combination: FDA accepts NDA for review

FDA approves Medtronic's MiniMed Paradigm integrated diabetes management system

Meridian Bioscience revises fiscal 2010 guidance, expects net sales between $145M and $153M

Low-impact, weight-bearing exercise does not affect bone density during weight loss

Study analyzes mortality rates of patients after coronary angioplasty

Obese patients face lower risk of sudden cardiac death compared to non-obese patients

Blocking RhoA enzyme increases survival in SMA mouse model

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Exercise News and Research

Latest Exercise News and Research

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Newsletters you may be interested in